| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication | 
|---|
| C010914 | 2,4-diaminotoluene | 2,4-diaminotoluene results in decreased expression of JARID2 mRNA | decreases expression | 20713471 
 | 
| C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene results in decreased expression of JARID2 mRNA | decreases expression | 20406850 
 | 
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of JARID2 mRNA | decreases expression | 20106945 
 | 
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of JARID2 mRNA | decreases expression | 20382639 
 | 
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of JARID2 mRNA | affects expression | 17555576 
 | 
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of JARID2 mRNA | increases expression | 17942748 
 | 
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of JARID2 mRNA | affects cotreatment|increases expression | 17942748 
 | 
| D006830 | Hydralazine | [Hydralazine co-treated with Valproic Acid] results in increased expression of JARID2 mRNA | affects cotreatment|increases expression | 17183730 
 | 
| C013038 | hydroxyhydroquinone | hydroxyhydroquinone results in increased expression of JARID2 mRNA | increases expression | 17572062 
 | 
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of JARID2 mRNA | decreases expression | 12057914 
 | 
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of JARID2 mRNA | affects binding|increases activity|increases expression | 19710929 
 | 
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of JARID2 mRNA | affects cotreatment|increases expression | 17942748 
 | 
| D014635 | Valproic Acid | [Hydralazine co-treated with Valproic Acid] results in increased expression of JARID2 mRNA | affects cotreatment|increases expression | 17183730 
 | 
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication | 
|---|
| MESH:D000014 | Abnormalities, Drug-Induced |  | Tetrachlorodibenzodioxin | 8.97 | 15322242	11752688	14514962 | 
| MESH:D000014 | Abnormalities, Drug-Induced |  | Valproic Acid | 8.97 | 8875741 | 
| MESH:D000015 | Abnormalities, Multiple |  | Valproic Acid | 4.07 | 19490988 | 
| MESH:D000152 | Acne Vulgaris |  | Ethinyl Estradiol | 4.16 | 17505938 | 
| MESH:D055371 | Acute Lung Injury |  | Lipopolysaccharides | 9.55 | 18653653	11850527 | 
| MESH:D055371 | Acute Lung Injury |  | pirinixic acid | 9.55 | 18653653 | 
| MESH:D000230 | Adenocarcinoma |  | Benzo(a)pyrene | 4.28 | 20127859	20464547 | 
| MESH:D000230 | Adenocarcinoma |  | Ethinyl Estradiol | 4.28 | 14692618 | 
| MESH:D000236 | Adenoma |  | Benzo(a)pyrene | 2.73 | 6695378 | 
| MESH:D018248 | Adenoma, Liver Cell |  | pirinixic acid | 10.56 | 16434500 | 
| MESH:D018248 | Adenoma, Liver Cell |  | Tetrachlorodibenzodioxin | 10.56 | 16835633 | 
| MESH:D000550 | Amblyopia |  | Valproic Acid | 5.45 | 17688650 | 
| MESH:D000740 | Anemia |  | Tetrachlorodibenzodioxin | 3.08 | 11748828 | 
| MESH:D001008 | Anxiety Disorders |  | Valproic Acid | 3.68 | 17497229 | 
| MESH:D017544 | Aortic Aneurysm, Abdominal |  | Benzo(a)pyrene | 4.25 | 19183758 | 
| MESH:D001161 | Arteriosclerosis |  | Ethinyl Estradiol | 3.64 | 11256880 | 
| MESH:D001169 | Arthritis, Experimental |  | Ethinyl Estradiol | 2.74 | 15885639 | 
| MESH:D001321 | Autistic Disorder |  | Valproic Acid | 1.99 | 19232924	18985861	18940202	17507914	19460635	18558336	17157402	18316065	18396377	15238991	17688650	20603192	18775368	18177632	16609825 | 
| MESH:D001714 | Bipolar Disorder |  | Valproic Acid | 3.14 | 20046352	17594078 | 
| MESH:D001778 | Blood Coagulation Disorders |  | pirinixic acid | 9.24 | 19483382 | 
| MESH:D001778 | Blood Coagulation Disorders |  | Tetrachlorodibenzodioxin | 9.24 | 12125929 | 
| MESH:D001836 | Body Weight Changes |  | Tetrachlorodibenzodioxin | 4.01 | 15340226 | 
| MESH:D001848 | Bone Diseases, Developmental |  | Tetrachlorodibenzodioxin | 8.31 | 15746008 | 
| MESH:D001848 | Bone Diseases, Developmental |  | Valproic Acid | 8.31 | 8888407 | 
| MESH:D001943 | Breast Neoplasms |  | 2,4-diaminotoluene | 1.92 | 11921183 | 
| MESH:D001943 | Breast Neoplasms |  | Benzo(a)pyrene | 1.92 | 17474063	20146248 | 
| MESH:D001943 | Breast Neoplasms |  | Tetrachlorodibenzodioxin | 1.92 | 20435547 | 
| MESH:D002277 | Carcinoma |  | Tetrachlorodibenzodioxin | 2.91 | 16835633 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | 2,6-dinitrotoluene | 1.77 | 16705839 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | Benzo(a)pyrene | 2.08 | 20419170 | 
| MESH:D006332 | Cardiomegaly |  | Tetrachlorodibenzodioxin | 2.44 | 18850075	18670907	16120746 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | 2,6-dinitrotoluene | 6.96 | 6135515 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 6.96 | 20889678 | 
| MESH:D002659 | Child Development Disorders, Pervasive | marker/mechanism |  |  | 21308764 | 
| MESH:D002659 | Child Development Disorders, Pervasive |  | Valproic Acid | 2.75 | 20734317 | 
| MESH:D018281 | Cholangiocarcinoma |  | Tetrachlorodibenzodioxin | 3.29 | 16835633 | 
| MESH:D002779 | Cholestasis |  | Ethinyl Estradiol | 8.09 | 17333356	17681005	15861022	16919318	11677210	16105132	17110522 | 
| MESH:D002779 | Cholestasis |  | pirinixic acid | 8.09 | 19176532 | 
| MESH:D002972 | Cleft Palate |  | Tetrachlorodibenzodioxin | 2.15 | 12621046	15340226	16354765	8697196	15668235 | 
| MESH:D000013 | Congenital Abnormalities |  | Tetrachlorodibenzodioxin | 3.18 | 14669216	17141729 | 
| MESH:D019465 | Craniofacial Abnormalities |  | Tetrachlorodibenzodioxin | 2.51 | 10048152	15322242	20055451 | 
| MESH:D019465 | Craniofacial Abnormalities |  | Valproic Acid | 2.51 | 8888407	16575769	17688650 | 
| MESH:D003490 | Cyanosis |  | 2,6-dinitrotoluene | 4.19 | 18551238 | 
| MESH:D003876 | Dermatitis, Atopic |  | pirinixic acid | 2.48 | 18249437 | 
| MESH:D003924 | Diabetes Mellitus, Type 2 |  | Tetrachlorodibenzodioxin | 1.69 | 17107852 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | 2,6-dinitrotoluene | 6.41 | 18551238	21346803 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Tetrachlorodibenzodioxin | 6.41 | 20420201 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Valproic Acid | 6.41 | 1733752	19641884 | 
| MESH:D004362 | Drug Toxicity |  | Tetrachlorodibenzodioxin | 2.86 | 11462148 | 
| MESH:D004421 | Dystonia |  | Valproic Acid | 4.20 | 1851702 | 
| MESH:D004487 | Edema |  | pirinixic acid | 7.00 | 12083418 | 
| MESH:D004487 | Edema |  | Tetrachlorodibenzodioxin | 7.00 | 11000095	12711302 | 
| MESH:D004489 | Edema, Cardiac |  | Tetrachlorodibenzodioxin | 4.12 | 16714409	15322242	18230668 | 
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental |  | Ethinyl Estradiol | 3.35 | 12538720 | 
| MESH:D004715 | Endometriosis |  | Tetrachlorodibenzodioxin | 3.15 | 10568697	9294722 | 
| MESH:D019446 | Endotoxemia |  | Lipopolysaccharides | 4.59 | 15328337	17637181	15821434 | 
| MESH:D004831 | Epilepsies, Myoclonic |  | Valproic Acid | 4.33 | 3659116	17275665 | 
| MESH:D004828 | Epilepsies, Partial |  | Valproic Acid | 4.13 | 16628512	3922381 | 
| MESH:D004827 | Epilepsy |  | Valproic Acid | 3.00 | 18234410	20417680 | 
| MESH:D004832 | Epilepsy, Absence |  | Valproic Acid | 3.71 | 7562514	6426943	6254150 | 
| MESH:D017029 | Epilepsy, Complex Partial |  | Valproic Acid | 4.47 | 7750514 | 
| MESH:D004830 | Epilepsy, Tonic-Clonic |  | Valproic Acid | 4.26 | 3659116 | 
| MESH:D004938 | Esophageal Neoplasms |  | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 4.46 | 20426865 | 
| MESH:D004938 | Esophageal Neoplasms |  | Benzo(a)pyrene | 4.46 | 16530937 | 
| MESH:D005124 | Eye Abnormalities |  | Tetrachlorodibenzodioxin | 3.12 | 11564622 | 
| MESH:D005234 | Fatty Liver |  | Ethinyl Estradiol | 13.89 | 15345470 | 
| MESH:D005234 | Fatty Liver |  | pirinixic acid | 13.89 | 20131406	19236843 | 
| MESH:D005234 | Fatty Liver |  | Valproic Acid | 13.89 | 14986274	19224547 | 
| MESH:D005313 | Fetal Death |  | Tetrachlorodibenzodioxin | 3.63 | 11858732 | 
| MESH:D005315 | Fetal Diseases |  | Valproic Acid | 5.10 | 16575769 | 
| MESH:D005317 | Fetal Growth Retardation |  | Valproic Acid | 4.29 | 8888407	18558336 | 
| MESH:D005334 | Fever |  | Lipopolysaccharides | 4.14 | 9205823	11852909 | 
| MESH:D005355 | Fibrosis |  | Tetrachlorodibenzodioxin | 3.12 | 20067830 | 
| MESH:D006058 | Gonadal Disorders |  | Tetrachlorodibenzodioxin | 4.81 | 10696789 | 
| MESH:D006330 | Heart Defects, Congenital |  | Benzo(a)pyrene | 6.67 | 20471113 | 
| MESH:D006330 | Heart Defects, Congenital |  | Tetrachlorodibenzodioxin | 6.67 | 10048152	11294989 | 
| MESH:D006333 | Heart Failure |  | pirinixic acid | 2.62 | 20558911 | 
| MESH:D006463 | Hemolytic-Uremic Syndrome |  | Lipopolysaccharides | 4.52 | 16366002 | 
| MESH:D006470 | Hemorrhage |  | Tetrachlorodibenzodioxin | 3.48 | 11000095 | 
| MESH:D006529 | Hepatomegaly |  | pirinixic acid | 8.85 | 16221962	18467677	19772884	19176532 | 
| MESH:D006529 | Hepatomegaly |  | Tetrachlorodibenzodioxin | 8.85 | 15340226	12621046	16120746 | 
| MESH:D006849 | Hydrocephalus |  | Valproic Acid | 5.06 | 17688650 | 
| MESH:D006869 | Hydronephrosis |  | Tetrachlorodibenzodioxin | 4.26 | 8697196	18606429	15340226	16959395	16354765 | 
| MESH:D006943 | Hyperglycemia |  | pirinixic acid | 3.31 | 20558911 | 
| MESH:D006973 | Hypertension |  | Tetrachlorodibenzodioxin | 1.95 | 18670907	18850075 | 
| MESH:D046110 | Hypertension, Pregnancy-Induced |  | Hydralazine | 4.80 | 16612254 | 
| MESH:D007021 | Hypospadias |  | Ethinyl Estradiol | 3.98 | 16569931	16945680 | 
| MESH:D007247 | Infertility, Female |  | Ethinyl Estradiol | 3.61 | 12013081 | 
| MESH:D007248 | Infertility, Male |  | Ethinyl Estradiol | 2.57 | 17937319 | 
| MESH:D007249 | Inflammation |  | Lipopolysaccharides | 5.30 | 12878042	17255318	17237260	9205823	17963957 | 
| MESH:D007249 | Inflammation |  | Tetrachlorodibenzodioxin | 5.30 | 12200463	12878042 | 
| MESH:D007333 | Insulin Resistance |  | pirinixic acid | 2.72 | 16306350 | 
| MESH:D019189 | Iron Metabolism Disorders |  | Lipopolysaccharides | 4.78 | 17255318 | 
| MESH:D007569 | Jaw Abnormalities |  | Tetrachlorodibenzodioxin | 3.48 | 16580747 | 
| MESH:D007680 | Kidney Neoplasms |  | 2,6-dinitrotoluene | 3.09 | 16705839 | 
| MESH:D015470 | Leukemia, Myeloid, Acute |  | Valproic Acid | 2.17 | 17596541	16294345 | 
| MESH:D007970 | Leukopenia |  | Lipopolysaccharides | 4.89 | 15821434 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Lipopolysaccharides | 3.53 | 12878042 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | pirinixic acid | 3.53 | 15474484 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Tetrachlorodibenzodioxin | 3.53 | 12878042 | 
| MESH:D008113 | Liver Neoplasms |  | 2,6-dinitrotoluene | 11.06 | 7678174 | 
| MESH:D008113 | Liver Neoplasms |  | Benzo(a)pyrene | 11.06 | 21137059	20195826 | 
| MESH:D008113 | Liver Neoplasms |  | pirinixic acid | 11.06 | 16377806	20007298	15890375 | 
| MESH:D008113 | Liver Neoplasms |  | Tetrachlorodibenzodioxin | 11.06 | 16984957 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | 2,6-dinitrotoluene | 6.01 | 2876784	6135515	2876786 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Tetrachlorodibenzodioxin | 6.01 | 12151625 | 
| MESH:D017563 | Lung Diseases, Interstitial |  | Valproic Acid | 4.48 | 17228818 | 
| MESH:D055370 | Lung Injury |  | Lipopolysaccharides | 4.18 | 21114838 | 
| MESH:D008175 | Lung Neoplasms |  | Benzo(a)pyrene | 2.22 | 17053015	18569708	18816296	20135361	20464547	20869020	18520028	6695378	20064080 | 
| MESH:D008175 | Lung Neoplasms |  | Tetrachlorodibenzodioxin | 2.22 | 19555203	11884234 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | 2,4-diaminotoluene | 3.66 | 11921183 | 
| MESH:D008881 | Migraine Disorders |  | Valproic Acid | 3.29 | 18803445	18765137 | 
| MESH:D009062 | Mouth Neoplasms |  | Benzo(a)pyrene | 3.30 | 16381670 | 
| MESH:D009135 | Muscular Diseases |  | pirinixic acid | 3.68 | 16239165 | 
| MESH:D009139 | Musculoskeletal Abnormalities |  | Valproic Acid | 4.17 | 8888407 | 
| MESH:D009190 | Myelodysplastic Syndromes |  | Valproic Acid | 3.23 | 17596541 | 
| MESH:D009203 | Myocardial Infarction |  | pirinixic acid | 2.19 | 19151258 | 
| MESH:D017202 | Myocardial Ischemia |  | Tetrachlorodibenzodioxin | 3.13 | 12213967 | 
| MESH:D015428 | Myocardial Reperfusion Injury |  | pirinixic acid | 3.05 | 16411023 | 
| MESH:D009336 | Necrosis |  | 2,6-dinitrotoluene | 4.05 | 7678174	18551238 | 
| MESH:D009369 | Neoplasms |  | Benzo(a)pyrene | 5.03 | 11141357 | 
| MESH:D009369 | Neoplasms |  | pirinixic acid | 5.03 | 17405874 | 
| MESH:D009421 | Nervous System Malformations |  | Tetrachlorodibenzodioxin | 3.37 | 14600291 | 
| MESH:D009436 | Neural Tube Defects |  | Valproic Acid | 3.21 | 16359493	8888407 | 
| MESH:D009765 | Obesity |  | pirinixic acid | 1.84 | 20558911 | 
| MESH:D009784 | Occupational Diseases |  | 2,6-dinitrotoluene | 3.56 | 16049721 | 
| MESH:D016584 | Panic Disorder |  | Ethinyl Estradiol | 3.84 | 11578682 | 
| MESH:D010382 | Peliosis Hepatis |  | Tetrachlorodibenzodioxin | 4.47 | 12520081 | 
| MESH:D011014 | Pneumonia |  | Lipopolysaccharides | 4.75 | 11605937	12224865 | 
| MESH:D017119 | Porphyria Cutanea Tarda |  | Tetrachlorodibenzodioxin | 3.72 | 18163543 | 
| MESH:D011297 | Prenatal Exposure Delayed Effects |  | Tetrachlorodibenzodioxin | 10.12 | 11399792	11896295	11222880	11118676 | 
| MESH:D011297 | Prenatal Exposure Delayed Effects |  | Valproic Acid | 10.12 | 20603192 | 
| MESH:D011471 | Prostatic Neoplasms |  | Benzo(a)pyrene | 2.95 | 17292933 | 
| MESH:D011537 | Pruritus |  | Ethinyl Estradiol | 3.51 | 16919318	15861022 | 
| MESH:D019310 | Pseudolymphoma |  | Valproic Acid | 4.76 | 11422049	12752131 | 
| MESH:D015427 | Reperfusion Injury |  | pirinixic acid | 2.45 | 19058328 | 
| MESH:D012130 | Respiratory Hypersensitivity |  | Lipopolysaccharides | 3.82 | 10835634 | 
| MESH:D015619 | Respiratory System Abnormalities |  | Tetrachlorodibenzodioxin | 4.00 | 18990726 | 
| MESH:D012208 | Rhabdomyosarcoma |  | Valproic Acid | 4.32 | 19155313 | 
| MESH:D012559 | Schizophrenia |  | Valproic Acid | 2.08 | 15737665	19110320 | 
| MESH:D012640 | Seizures |  | 2,6-dinitrotoluene | 6.25 | 18551238 | 
| MESH:D012640 | Seizures |  | Valproic Acid | 6.25 | 14763951	17978042	3137016	15475178	1511512	11738929	11044598	16876388 | 
| MESH:D012878 | Skin Neoplasms |  | Benzo(a)pyrene | 5.67 | 10029692	19755658 | 
| MESH:D012878 | Skin Neoplasms |  | Tetrachlorodibenzodioxin | 5.67 | 16192470 | 
| MESH:D013088 | Spermatocele |  | Ethinyl Estradiol | 4.16 | 16709447 | 
| MESH:D016135 | Spinal Dysraphism |  | Valproic Acid | 3.89 | 19490988 | 
| MESH:D013226 | Status Epilepticus |  | Valproic Acid | 4.76 | 12833885 | 
| MESH:D013274 | Stomach Neoplasms |  | Benzo(a)pyrene | 1.56 | 2093021	20155912 | 
| MESH:D013921 | Thrombocytopenia |  | Lipopolysaccharides | 4.30 | 15821434 | 
| MESH:D019851 | Thrombophilia |  | Ethinyl Estradiol | 3.77 | 11994571 | 
| MESH:D013927 | Thrombosis |  | Ethinyl Estradiol | 3.28 | 15669648 | 
| MESH:D013959 | Thyroid Diseases |  | Tetrachlorodibenzodioxin | 4.12 | 12697716 | 
| MESH:D014178 | Translocation, Genetic |  | Valproic Acid | 5.45 | 17262798 | 
| MESH:D020194 | Unverricht-Lundborg Syndrome |  | Valproic Acid | 4.71 | 3119515 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | 2,6-dinitrotoluene | 5.14 | 16049721 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Benzo(a)pyrene | 5.14 | 17053015 | 
| MESH:D014564 | Urogenital Abnormalities |  | Valproic Acid | 4.82 | 8888407 | 
| MESH:D014571 | Urologic Neoplasms |  | 2,6-dinitrotoluene | 4.51 | 10091137 | 
| MESH:D014594 | Uterine Neoplasms |  | Ethinyl Estradiol | 3.46 | 14692618 | 
| MESH:D054079 | Vascular Malformations |  | Tetrachlorodibenzodioxin | 4.81 | 12125929 | 
| MESH:D020246 | Venous Thrombosis |  | Ethinyl Estradiol | 3.68 | 14671159	15869587 | 
| MESH:D019282 | Wasting Syndrome |  | Tetrachlorodibenzodioxin | 4.47 | 15886252 |